JP2012130342A5 - - Google Patents

Download PDF

Info

Publication number
JP2012130342A5
JP2012130342A5 JP2012009515A JP2012009515A JP2012130342A5 JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5 JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5
Authority
JP
Japan
Prior art keywords
side region
nucleic acid
acid molecule
stranded rna
bases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012009515A
Other languages
English (en)
Japanese (ja)
Other versions
JP5804642B2 (ja
JP2012130342A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012009515A priority Critical patent/JP5804642B2/ja
Priority claimed from JP2012009515A external-priority patent/JP5804642B2/ja
Publication of JP2012130342A publication Critical patent/JP2012130342A/ja
Publication of JP2012130342A5 publication Critical patent/JP2012130342A5/ja
Application granted granted Critical
Publication of JP5804642B2 publication Critical patent/JP5804642B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012009515A 2010-07-08 2012-01-20 遺伝子発現制御のための一本鎖核酸分子 Expired - Fee Related JP5804642B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012009515A JP5804642B2 (ja) 2010-07-08 2012-01-20 遺伝子発現制御のための一本鎖核酸分子

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
JP2010156122 2010-07-08
JP2010156122 2010-07-08
JP2010174915 2010-08-03
JP2010174915 2010-08-03
JP2010230806 2010-10-13
JP2010230806 2010-10-13
JP2010230808 2010-10-13
JP2010230808 2010-10-13
JP2010269823 2010-12-02
JP2010269823 2010-12-02
JP2010269824 2010-12-02
JP2010269824 2010-12-02
JP2012009515A JP5804642B2 (ja) 2010-07-08 2012-01-20 遺伝子発現制御のための一本鎖核酸分子

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011537086A Division JP4968811B2 (ja) 2010-07-08 2011-07-08 遺伝子発現制御のための一本鎖核酸分子

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015150156A Division JP6162182B2 (ja) 2010-07-08 2015-07-29 遺伝子発現制御のための一本鎖核酸分子

Publications (3)

Publication Number Publication Date
JP2012130342A JP2012130342A (ja) 2012-07-12
JP2012130342A5 true JP2012130342A5 (cg-RX-API-DMAC7.html) 2013-10-03
JP5804642B2 JP5804642B2 (ja) 2015-11-04

Family

ID=45441339

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011537086A Expired - Fee Related JP4968811B2 (ja) 2010-07-08 2011-07-08 遺伝子発現制御のための一本鎖核酸分子
JP2012009515A Expired - Fee Related JP5804642B2 (ja) 2010-07-08 2012-01-20 遺伝子発現制御のための一本鎖核酸分子
JP2015150156A Expired - Fee Related JP6162182B2 (ja) 2010-07-08 2015-07-29 遺伝子発現制御のための一本鎖核酸分子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011537086A Expired - Fee Related JP4968811B2 (ja) 2010-07-08 2011-07-08 遺伝子発現制御のための一本鎖核酸分子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015150156A Expired - Fee Related JP6162182B2 (ja) 2010-07-08 2015-07-29 遺伝子発現制御のための一本鎖核酸分子

Country Status (17)

Country Link
EP (2) EP2431466B1 (cg-RX-API-DMAC7.html)
JP (3) JP4968811B2 (cg-RX-API-DMAC7.html)
KR (1) KR101849798B1 (cg-RX-API-DMAC7.html)
CN (2) CN104818276B (cg-RX-API-DMAC7.html)
AU (1) AU2011274854B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013000481A2 (cg-RX-API-DMAC7.html)
CA (1) CA2804511C (cg-RX-API-DMAC7.html)
DK (2) DK2933333T3 (cg-RX-API-DMAC7.html)
ES (2) ES2670017T3 (cg-RX-API-DMAC7.html)
HU (2) HUE037500T2 (cg-RX-API-DMAC7.html)
MX (1) MX352568B (cg-RX-API-DMAC7.html)
NZ (2) NZ606232A (cg-RX-API-DMAC7.html)
PT (2) PT2431466E (cg-RX-API-DMAC7.html)
RU (1) RU2628311C2 (cg-RX-API-DMAC7.html)
SG (2) SG186899A1 (cg-RX-API-DMAC7.html)
TW (2) TWI527901B (cg-RX-API-DMAC7.html)
WO (1) WO2012005368A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
WO2013133393A1 (ja) * 2012-03-07 2013-09-12 学校法人東京医科大学 Vegf遺伝子の発現抑制用一本鎖核酸分子
US20150105442A1 (en) 2012-03-29 2015-04-16 Aqua Therapeutics Co., Ltd. Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule
EP2857513A4 (en) * 2012-05-26 2016-05-25 Bonac Corp Single-stranded nucleic acid molecule controlling the expression of a gene transporter
WO2015099122A1 (ja) 2013-12-26 2015-07-02 学校法人東京医科大学 遺伝子発現制御のための人工ミミックmiRNAおよびその用途
RU2697094C2 (ru) 2013-12-27 2019-08-12 Бонак Корпорейшн ИСКУССТВЕННАЯ мкРНК С СООТВЕТСТВИЕМ ДЛЯ КОНТРОЛЯ ЭКСПРЕССИИ ГЕНОВ И ЕЕ ПРИМЕНЕНИЕ
EP3235906B1 (en) * 2014-12-15 2021-06-23 Bonac Corporation Single-stranded nucleic acid molecule for inhibiting tgf- beta 1 expression
CA2971827A1 (en) 2014-12-27 2016-06-30 Bonac Corporation Naturally occuring mirna for controlling gene expression, and use of same
CN108064289A (zh) 2015-03-27 2018-05-22 株式会社博纳克 具有递送功能和基因表达调控能力的单链核酸分子
PL3369816T3 (pl) 2015-10-30 2024-07-22 Toray Industries, Inc. KOMPOZYCJA STABILNIE ZAWIERAJĄCA CZĄSTECZKĘ JEDNONICIOWEGO KWASU NUKLEINOWEGO, KTÓRA HAMUJE EKSPRESJĘ GENU TGF-β1
HK1259060A1 (en) * 2015-12-29 2019-11-22 国立大学法人北海道大学 Single-stranded nucleic acid molecule inhibiting expression of prorenin gene or prorenin receptor gene, and use thereof
CA3013179A1 (en) 2016-01-30 2017-08-03 Bonac Corporation Artificial single guide rna and use thereof
EP3604528A4 (en) 2017-03-31 2021-01-13 Bonac Corporation CYCLIC NUCLEIC ACID MOLECULE HAVING A GENE EXPRESSION CONTROL FUNCTION
JPWO2018199338A1 (ja) * 2017-04-27 2020-03-12 国立大学法人広島大学 B型肝炎治療用核酸分子
EP3659609B1 (en) 2017-07-28 2024-05-08 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for fibrosis
IL273245B2 (en) * 2017-09-15 2025-03-01 Commw Scient Ind Res Org RNA molecules
US11298371B2 (en) 2017-10-11 2022-04-12 Nitto Denko Corporation Regulation of nucleic acid molecule expression
JPWO2019074110A1 (ja) * 2017-10-13 2020-12-24 株式会社ボナック 一本鎖核酸分子およびその製造方法
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
WO2019189722A1 (ja) 2018-03-30 2019-10-03 東レ株式会社 ヘアピン型一本鎖rna分子の製造方法
WO2019189591A1 (ja) 2018-03-30 2019-10-03 住友化学株式会社 一本鎖rnaの製造方法
WO2020071407A1 (ja) * 2018-10-02 2020-04-09 東レ株式会社 ヘアピン型一本鎖rna分子の製造方法
WO2020152869A1 (ja) 2019-01-25 2020-07-30 杏林製薬株式会社 線維症治療剤
KR20220079832A (ko) 2019-10-11 2022-06-14 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
WO2021153047A1 (ja) 2020-01-29 2021-08-05 住友化学株式会社 核酸オリゴマーの製造方法
KR20220133919A (ko) 2020-01-29 2022-10-05 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
JP7613130B2 (ja) * 2020-03-25 2025-01-15 味の素株式会社 リガーゼ変異体
CN115335387A (zh) 2020-03-27 2022-11-11 住友化学株式会社 核酸寡聚物的制造方法
CN115867559A (zh) 2020-07-09 2023-03-28 住友化学株式会社 核酸寡聚物的制造方法
CN116209668A (zh) 2020-09-24 2023-06-02 住友化学株式会社 核酸寡聚物的制造方法
US20250051256A1 (en) 2021-09-28 2025-02-13 Sumitomo Chemical Company, Limited Production method for purified dichloroacetic acid
KR20240162536A (ko) 2022-03-23 2024-11-15 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
JP7201190B1 (ja) 2022-06-03 2023-01-10 株式会社セツロテック 遺伝子改変動物由来の動物繊維
JPWO2024089953A1 (cg-RX-API-DMAC7.html) 2022-10-27 2024-05-02

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
FR2790757B1 (fr) * 1999-03-09 2003-08-01 Bioalliance Pharma Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant.
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
WO2003072745A2 (en) * 2002-02-22 2003-09-04 Eshleman James R Antigene locks and therapeutic uses thereof
EP3222724B1 (en) * 2002-08-05 2018-10-31 Silence Therapeutics GmbH Further novel forms of interfering rna molecules
US20040058886A1 (en) * 2002-08-08 2004-03-25 Dharmacon, Inc. Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
AU2004276684A1 (en) * 2003-09-30 2005-04-07 Anges Mg, Inc. Staple type oligonucleotide and drug comprising the same
AU2005327517B2 (en) * 2004-06-30 2011-05-26 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a non-phosphate backbone linkage
WO2006074108A2 (en) * 2004-12-30 2006-07-13 Hauser Todd M Compositions and methods for modulating gene expression using self-protected oligonucleotides
KR100848666B1 (ko) * 2006-03-17 2008-07-28 (주)바이오니아 NF-k B의 발현을 억제하는 s i RNA
JP5296328B2 (ja) 2007-05-09 2013-09-25 独立行政法人理化学研究所 1本鎖環状rnaおよびその製造方法
WO2009074076A1 (en) * 2007-11-29 2009-06-18 Suzhou Ribo Life Science Co., Ltd A complex molecule interfering the expression of target genes and its preparing methods
US20110159586A1 (en) * 2007-12-07 2011-06-30 Halo-Bio Rnai Therapeutics, Inc. Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
WO2009102081A1 (ja) * 2008-02-15 2009-08-20 Riken 環状1本鎖核酸複合体およびその製造方法
JP5187580B2 (ja) 2008-12-26 2013-04-24 丸紅建材リース株式会社 掘削機の泥土飛散防止装置
JP2010174915A (ja) 2009-01-27 2010-08-12 Toyota Motor Corp 高圧ガスタンク
JP5233790B2 (ja) 2009-03-26 2013-07-10 船井電機株式会社 液晶モジュール
JP5449815B2 (ja) 2009-03-26 2014-03-19 住友化学株式会社 偏光板の製造方法
JP2010269823A (ja) 2009-05-21 2010-12-02 British American Tobacco Japan Kk 喫煙品用容器
JP4885255B2 (ja) 2009-05-21 2012-02-29 株式会社エフピコ 包装用容器

Similar Documents

Publication Publication Date Title
JP2012130342A5 (cg-RX-API-DMAC7.html)
US12486505B2 (en) Oligonucleotide compositions and methods thereof
US20240117347A1 (en) Oligonucleotide compositions and methods thereof
Bhatti et al. Emerging role of non‐coding RNA in health and disease
US10724035B2 (en) Oligonucleotide compositions and methods thereof
Van Rooij et al. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
Kesy et al. A short chemically modified dsRNA-binding PNA (dbPNA) inhibits influenza viral replication by targeting viral RNA panhandle structure
JP2012029693A5 (cg-RX-API-DMAC7.html)
RU2013105329A (ru) Молекула одноцепочечной нуклеиновой кислоты для контроля экспрессии генов
JP2009159971A5 (cg-RX-API-DMAC7.html)
JP2009219504A5 (cg-RX-API-DMAC7.html)
JP2012506254A5 (cg-RX-API-DMAC7.html)
JP2012050449A5 (cg-RX-API-DMAC7.html)
JP2017079776A5 (cg-RX-API-DMAC7.html)
JP2013510561A5 (cg-RX-API-DMAC7.html)
JP2011500858A5 (cg-RX-API-DMAC7.html)
JP2012516856A5 (cg-RX-API-DMAC7.html)
JP2012505657A5 (cg-RX-API-DMAC7.html)
JP2013537404A5 (cg-RX-API-DMAC7.html)
Han et al. Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers
Baud et al. Partners in crime: Proteins implicated in RNA repeat expansion diseases
Liang et al. Ring-structured DNA and RNA as key players in vivo and in vitro
Sharma et al. Engineering circular RNA for molecular and metabolic reprogramming
JP2012085645A5 (cg-RX-API-DMAC7.html)
KR102131883B1 (ko) Cre 재조합효소 의존적으로 TREK-1 발현이 억제되는 항우울 동물모델 및 이의 제조방법